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Poisoning events and chronic exposure to
cholinesterase inhibitors, organophosphates
(OPs), and carbamates have traditionally been
associated with neurotoxic consequences, such
as poor neurobehavioral performance in some
cognitive domains such as information pro-
cessing and memory (Abou-Donia 2003;
Wesseling et al. 2002; Yokoyama et al. 1998)
or delayed neuropathy induced by certain OPs
(Eyer 1995; Jamal 1997). The following two
cases show neurocognitive deﬁcits after differ-
ent types of poisoning events by cholinesterase
inhibitors (carbamates and OPs): the ﬁrst case
(AMF) was due to accidental ingestion of a
carbamate compound, and the second (PVM)
was a greenhouse worker with a history of
repeated poisonings while working with OPs,
carbamates, or both together. Both patients
received emergency-room care for overcholin-
ergic syndrome by cholinesterase inhibitors.
Three and 12 months later, cholinesterase lev-
els and neuropsychological performance were
assessed following protocols proposed for
neurotoxicology evaluation (Fiedler 1996;
White and Proctor 1995).
Case 1
In January 1998, AMF, a 55-year-old right-
handed female, was attended at the emergency
room in the Hospital de Poniente (Almería,
Spain) after accidentally drinking a glass of
methomyl, a carbamate pesticide. This com-
pound had been prepared by her son and kept
in the refrigerator in a bottle for later use in the
greenhouse. AMF drank a glass, thinking it
was a refreshment. Half an hour later, she was
taken to the hospital by her husband, suffering
from physical discomfort. Upon the arrival at
the emergency room, she presented a Glasgow
Coma Scale (GCS) of 15, and her symptoms
included perspiration, tremors, myosis, respi-
ratory problems, sialorrhea, and vomiting.
The patient did not present hypoxia, coma, or
loss of consciousness [butyrylcholinesterase
(BuChE) levels shown in Figure 1]. She was
treated in the hospital with gastric lavage, acti-
vated charcoal, cathartics, and antiemetics.
She was released 1 week later without further
medical treatment. No neurological or physi-
cal disturbances were observed. Once at
home, she reported slowness, subtle disorien-
tation, and attention and memory problems
in daily activities, such as recalling telephone
numbers or cooking.
A year later in a medical follow-up visit,
she reported that she felt well: Orientation
and speed had improved, as had competency
in routine abilities such as cooking, but mem-
ory problems remained. No other physical
problems were recorded. The brain computed
tomography (CT) done at this time was con-
sidered normal.
Summary of neuropsychological function-
ing. AMF underwent a broad-based clinical
neuropsychological examination in April 1998
and April 1999. For some of the tests [Logical
Memory test and Rey Auditory Verbal
Learning tests (Rey 1964)], an alternative form
was used in the second evaluation, to avoid
effects of learning and practice. During the
interview, AMF reported a low level of educa-
tion, not having finished obligatory primary
school. Her primary role was as a housewife,
managing money and the home, raising her
children, and sometimes helping in agricul-
tural work. Her estimated IQ was 95 (Bilbao-
Bilbao and Seisdedos 2004), and her corrected
score on the Mini Mental State Examination
(Lobo et al. 1979) was 28, indicating the
absence of dementia. She adequately per-
formed tests of single-word reading, basic writ-
ten arithmetic, and semantic knowledge. Her
writing skills were not evaluated, except for her
name. Each outcome was evaluated in relation
to her educational level, sex, estimated IQ, and
age, bearing in mind that the variable “educa-
tion” has an inﬂuence on an individual’s over-
all neuropsychological performance.
In the first assessment, her performance
was below expectation for her estimated pre-
morbid IQ in the domains of attention,
memory, motor skill, and constructional
abilities (Table 1). A minimal depression was
also registered.
A year later, April 1999, although AMF
showed a slight improvement in neuro-
psychological testing, her performance was
still lower than the accepted cutoff point,
showing that the deﬁcits in attention, mem-
ory, motor, and constructional abilities per-
sisted (Table 1).
Case 2
PVM, a 26-year-old right-handed male, was
most recently poisoned (February 1998) by a
mixture of pesticides [carbamate (methomyl)
and pyrethroid (cypermethrin)] while spray-
ing in a greenhouse without any personal
safety equipment. PVM attended the emer-
gency room at the Hospital de Poniente
(Almería, Spain) because of cephalalgia,
abdominal pain, and vomiting. His GCS was
15 (BuChE levels shown in Figure 1). He was
given a 2-week prescription for atropine
(1.2 mg) and antiemetics and was released the
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Here we describe two cases of carbamate poisoning. Patients AMF and PVM were accidentally
poisoned by cholinesterase inhibitors. The medical diagnosis in both cases was overcholinergic
syndrome, as demonstrated by exposure to cholinesterase inhibitors. The widespread use of
cholinesterase inhibitors, especially as pesticides, produces a great number of human poisoning
events annually. The main known neurotoxic effect of these substances is cholinesterase inhibition,
which causes cholinergic overstimulation. Once AMF and PVM had recovered from acute intoxica-
tion, they were subjected to extensive neuropsychological evaluation 3 and 12 months after the poi-
soning event. These assessments point to a cognitive deﬁcit in attention, memory, perceptual, and
motor domains 3 months after intoxication. One year later these sequelae remained, even though
the brain magnetic resonance imaging (MRI) and computed tomography (CT) scans were inter-
preted as being within normal limits. We present these cases as examples of neuropsychological
proﬁles of long-term sequelae related to acute poisoning by cholinesterase inhibitor pesticides and
show the usefulness of neuropsychological assessment in detecting central nervous system dysfunc-
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Environmental Medicine Case Reportnext day. He had been poisoned with OPs
and carbamates six times previously (all due to
the absence of personal safety equipment),
with three of them documented. The first
took place in June 1996 while he was spraying
with methomyl; upon arrival at the hospital,
his symptoms were dizziness and perspiration.
The second happened in September 1996 while
he was working with a mixture of methomyl
and chlorpyrifos (OP); in addition to cholin-
esterase inhibition, the patient showed tremors,
perspiration, respiratory problems, sialorrhea,
and vomiting. The third documented poison-
ing event happened in December 1996 when
he was spraying with a mixture of methomyl
and chlorpyrifos; his symptoms were vomiting,
myosis, abdominal pain, perspiration, and res-
piratory problems. In these four events, the
medical diagnosis was overcholinergic syn-
drome. No coma, hypoxia, or convulsions were
recorded in any of these events. In all cases,
treatment in the hospital was gastric lavage and
atropine, and the poisonings were resolved
i n<2 4h r .
PVM underwent cognitive testing in May
1998 and May 1999. During the first inter-
view, he reported mnesic problems, such as
remembering telephone numbers and the
events of the previous day, but complained of
no physical symptoms. He had completed sec-
ondary school and had been working in agri-
culture for 10 years. His estimated IQ was
105, and he obtained a score of 30 in the Mini
Mental State Examination. Each outcome was
evaluated in relation to his educational level,
estimated IQ, sex, and age. Tests of single-
word reading, writing skills, basic mental, and
written arithmetic and semantic knowledge
were completed correctly. Physical and neuro-
logical assessment did not show any alteration
at the time of the neuropsychological testing.
He did not receive pharmacological treatment.
During the second assessment in May
1999, he reported that he continued working
in the greenhouse. No further poisoning
events had been recorded during this time.
The magnetic resonance image (MRI) taken a
year after the last poisoning event did not
reveal any evidence of brain injury. He
reported no physical complaints. 
Summary of neuropsychological function-
ing. In 1998, PVM’s performance was below
expectation for estimated premorbid abilities
in the domains of motor skills and short and
long-term memory. Deficits at the level of
learning new information were detected on
several tasks, but he showed forgetting of
information over a delay only in visuospatial
tasks. His outcomes reﬂected slowness in the
copying of a complex ﬁgure or the fulﬁllment
of a complex attentional task (Table 1).
When comparing his 1999 performance
with that of 1998, the speed of processing
appeared to improve, although probably due
to a practice effect. Yet, disturbances remained
in the short- and long-term logical memory, as
well as in visual memory, and in motor tasks
such as alternation and coordination, which
implies programming and motor regulation
injury. His score for depression was in the
normal range, whereas the Taylor Anxiety
Scale score (Taylor 1953) showed a subtle
increase, although still in normal range.
During the assessment sessions, the patient
was cooperative but very worried about the
possibility of sequelae.
Discussion
Cholinesterase inhibitors, OPs, and carbamates
are powerful insecticides widely used in agri-
culture. However, they are acutely toxic to
humans and may cause poisoning as a result of
exposure in the workplace, or as accidental or
suicidal events (Fengsheng 2000). This is the
case in the intensive agriculture industry in
southern Spain, where a large number of intox-
ications have been documented. In only the
ﬁrst half of 2000, 49 occupational poisoning
events were recorded [Sociedad Española de
Sanidad Ambiental y Asociación Española de
Toxicología (SESA/AET) 2000]. The toxic
compounds that produced those events were
insecticides, mainly OPs (59%), followed by
carbamates (34%) and organochlorides (10%).
The main neurotoxic reaction after absorp-
tion of cholinesterase inhibitors is acute cholin-
ergic syndrome due to the inhibition of the
acetylcholinesterase (AChE) enzyme, which is
reversible in case of the carbamates and irre-
versible in case of OPs. This inhibition leads to
an accumulation of acetylcholine (ACh) at
synapses, causing overstimulation and subse-
quent disruption of transmission of impulses in
the central, peripheral, and autonomic nervous
systems (Martín-Rubí et al. 1995; Storm et al.
2000). Symptoms in patients who experience
cholinesterase inhibitor poisonings may
include dry mouth, fasciculation, tremor, agita-
tion, ataxia, weakness (Steenland 1996), ten-
sion, anxiety, irritability, restlessness, and
headaches (Stephens et al. 1995). Once the
cholinergic imbalance has been corrected,
many of the symptoms usually disappear.
Several studies have shown the existence of
both short- and long-term neuropsychological
symptoms after acute intoxication by pesti-
cides, mainly OPs. The first publications of
acute effects reported neurocognitive sequelae,
anxiety, irritability, insomnia (Tabershaw and
Cooper 1966), loss of memory (Holmes and
Gaon 1956), and reactions similar to schizo-
phrenia and depressive symptoms (Gershon
and Shaw 1961). The first controlled study
assessing workers who suffered acute poison-
ing from cholinesterase inhibitor compounds
and/or organochlorides was reported by
Savage et al. (1988). The poisoned group
showed deteriorated intellectual functioning,
academic skills, abstraction, reasoning, motor
skills, and sensitivity to social stress. No signif-
icant difference between poisoned subjects and
controls was found on audiometric tests, oph-
thalmic tests, electroencephalograms, or clini-
cal serum and blood biochemistry evaluations
(Savage et al. 1988). Later, Rosenstock et al.
(1991) reported a retrospective study in which
36 workers were tested, all of whom had suf-
fered acute OP intoxication 1–3 years earlier.
Lifetime work experience data (years worked,
other toxics) and recent exposure were con-
trolled. Rosenstock et al. (1991) found evi-
dence of brain damage with impairment of
short-term memory, attention, sequencing
and problem solving, visuospatial cognition,
and depression. A third study compared an
OP-poisoned group with control subjects
matched in sex, age, and educational level
(Steenland et al. 1996). Cholinesterase inhibi-
tion was also registered for the poisoned
group. Tests included a neurological physical
examination, and nerve conduction, vibrotac-
tile sensitivity, neurobehavioral, and postural
sway tests. The results pointed to neurocogni-
tive deficits and disturbed peripheral nerve
function. The poisoned group had poor scores
in neuropsychological tests, such as sustained
attention, and showed confusion and tension
in the mood scales (Steenland et al. 1996).
In another study, Yokoyama et al. (1998)
assessed neuropsychological sequelae in a small
group of people who had suffered acute sarin
poisoning in a terrorist attack 6–8 months ear-
lier. The authors assessed serum cholinesterase
activity in patients on the day of poisoning,
controlling for age, education level, alcohol
consumption, and smoking status. Deﬁcits in
psychomotor performance and posttraumatic
disorders, together with disturbances in brain-
evoked potentials, were found.
In a recent study carried out in Costa
Rica, Wesseling et al. (2002) compared neuro-
behavioral performance between two groups
of farmers with previous acute intoxications by
OP or carbamates. Plasma cholinesterase was
assessed for each group of subjects. Two years
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Figure 1. Plasmatic cholinesterase levels (BuChE)
of both patients immediately after poisoning and at
3 months and 1 year later, as well as enzymatic
activity levels of PVM’s previous intoxications in
1996. The two dashed lines indicate the normal
range.later, the patients showed long-term sequelae:
deficits in visuo- and psychomotor tasks.
Performance of the OP-poisoned subjects was
worse than that of the farmers who had been
poisoned by carbamates.
Although the dysfunctions found are dif-
ferent depending on the task, the type of pesti-
cide, and the severity of poisoning, the three
studies (Rosenstock et al. 1991; Wesseling
et al. 2002; Yokoyama et al. 1998) have a
common profile of deteriorated intellectual
functioning, academic abilities, distress, motor
skills, posttraumatic stress, confusion, and ten-
sion, as well as self-reported symptoms of
depression, irritability, and confusion.
The pattern of cognitive deficit that we
report here is generally quite typical of the pat-
tern of deﬁcits reported after acute poisoning
events. AMF and PVM displayed decreases in
the speed of processing, visuospatial function-
ing, and short-term visual and logical memory
deﬁcits. Programming motor activity was also
damaged, and minor anxiety was recorded. In
both cases, neuropsychological dysfunction
remained a year later in the absence of bio-
chemical abnormality or structural brain dam-
age, as shown by CT scan and MRI, in line
with several previous reports (Jamal 1997).
It could be argued that the results
obtained by AMF on the Beck Depression
Inventory (Beck et al. 1961) may explain some
of the deﬁcits found. Some authors (Buckelew
and Hannay 1986; Gass and Daniel 1990;
Meyers and Meyers 1996) suggest that high
degrees of depression or anxiety can produce
alterations in neuropsychological performance
(including some of the tests we used, e.g., Rey-
Osterrieth Complex Figure (ROCF), Trail-
Making Test B, block design; Table 1). AMF
suffered a minimal degree of depression that
had mostly disappeared a year later, whereas
neurobehavioral deficits remained; thus, it
seems that affective deregulation cannot
account for our results for AMF.
Repeated administrations of the same test
can produce practice effects, especially in tests
of verbal memory (Benedict and Zgaljardic
1998; Theisen et al. 1998). To avoid this
learning effect, alternative forms of Logical
Memory and Rey Auditory Verbal Learning
(RAVL) tests were used for retesting both
patients. Nevertheless, very small increases
occurred in the second administration of the
nonverbal tests, such as the score on the time
to copy and the recall of the complex ﬁgure. In
general, the subtle improvement shown in the
second assessment indicates a recovery effect,
which reinforces the idea that neither educa-
tion nor poor intellectual abilities fully explain
the deﬁcits in neuropsychological performance.
Finally, the last poisoning event suffered
by PVM was due to a mixture of carbamate
and pyrethroid. Although pyrethroid has been
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Table 1. Test scores of patients AMF and PVM on tests of general cognitive abilities and emotional state, and interpretation according to accepted cutoff points.
AMF PVM
Test 3 months 1 year Cutoff norms 3 months 1 year Cutoff norms
Attention
Digit span WAIS backwarda 3 3 4.1 ± 0.6b,c 4 5 4.30 ± 1.11
Stroop test NA NA 52 52 < 50th percentiled
Letter cancellation A 3 errors 2 errors 0 errorse 0 errors 0 errors 0 errorse
Trail-Making A  NA NA 40 sec 42 sec Test 18.5 ± 5.1c
Retest 16.2 ± 5.0
Trail-Making B  NA NA 90 sec 92 sec Test 41.6 ± 11.4c
Retest 34.0 ± 12.7
Digit symbol WAIS  5 7 > 10 12 12 > 10
Reasoning
Picture completion WAIS  7 8 > 10 12 12 > 10
Similarities WAIS 4 6 > 10 14 12 > 10
Memory
Digit span WAIS forward 4 4 4.9 ± 0.8c 5 5 5.98 ± 1.12c
RAVL test (trial 1–5)f 2, 5, 6, 8, 8 3, 5, 7, 8, 8 Means 4.86, 6.81 4, 6, 10, 11, 13 4, 6, 9, 12, 13 Means 7.4, 10.5, 
8.66, 9.40, 9.71c 12.2, 13.0, 13.4c
RAVL test after delay 5 6 7.81 ± 3.7 11 11 12.1 ± 2.8
Logical Memory A, immediate recall (WMS)g 5 5 13.0 ± 2.3h 10 7 13.8 ± 6.0h
Logcal Memory A after delay  5 4 10.2 ± 4.0 8 6 13.0 ± 5.0
ROCF immediate recall  9 10  14.45 ± 5.3e 11.5 12 18.88 ± 6.1e
ROCF delayed recall  9.5 10 13.4 ± 6.0e 12 12.5 20.00 ± 6.4e
BVRTi 9 11 12.8 13 12 13.7 
Visuospatial/visual motor
ROCF copy quality  10 10 30.5 ± 4.7c 25 28 33.0 ± 2.8c
ROCF copy time 5 min 20 sec 4 min 30 sec < 3 minj 3 min 56 sec 3 min 50 sec > 3 minj
BVRFTh 26 27 Mean 31.00k 28 28 Mean  31.00k
Astereognosis 5 5 Mean  5e 5 5 Mean 5e
Poppelreuter’s test 10 10 9 ± 1e 10 10 9 ± 1e
Block design WAIS 5 6 > 10 12 12 > 10
Ideomotor praxis  0 errors  0 errors 0 errorsl 0 errors 0 errors 0 errorsl
Ideational praxis  0 errors  0 errors  0 errorsl 0 errors  0 errors  0 errorsl
Reciprocal inhibition  0 errors  0 errors  0 errorse 3 errors 1 error 0 mistakese
Motor alternate  Notm Not Correcte Not Not Correcte
Motor coordination  Notn Not Correct Correct Correct Correct
Rhythm reproduction  4 6 9 ± 2e 4 5 10 ± 2e
Language
Boston Naming Testo 45 43 49.2 ± 5.6c 54 55 57.8 ± 2.1c
Emotional status
Beck Depression Inventory 14 10 10–15: minimal depression 6 6 0–9 normal range
Taylor Anxiety Scalep 33 21 16–45 18 20 14–45 
Abbreviations: BVRFT, Benton Visual Recognition Form Test; BVRT, Benton Visual Retention Test; NA, not available; RAVL, Rey Auditory Verbal Learning; ROCF, Rey-Osterrieth Complex
Figure; WAIS, Wechsler Adult Intelligence Scale; WMS, Wechsler Memory Scale.
aWeschler (1993). bMean ± SD. cMitrushina et al. (1999). dGolden (1994). eLezak (1995). fRey (1964). gWeschler (1997). hSpreen and Strauss (1998). iBenton et al. (1994). jRey (1997). kRey
and Sivan (1995). lStrub and Black (1988). mThe same sequence of alternation in two essays of seven trials each. nThe movement was not correctly performed in either of the trials.
oGoodglass and Kaplan (1990). pTaylor (1953).considered among the safest classes of insecti-
cides available (Dorman and Beasley 1991),
there have been few reports of systemic poison-
ing in humans by pyrethroid insecticides. In a
review on this topic, Müller-Mohnssen (1999)
reported that the symptoms after an acute
intoxication (burning sensation of eyes and
face, painful irritation of respiratory mucosa,
vertigo, and disturbed consciousness) and the
period of latency and symptoms of subacute
intoxication (tingling, sensation of burning,
and sensibility disorder) are dissimilar to those
reported after OP and/or carbamate poisoning
events, and dissimilar to those presented by
PVM upon arrival at the hospital. In fact, it is
difficult to attribute the neuropsychological
deﬁcit to pyrethroid intoxication when PVM’s
diagnosis was overcholinergic syndrome by
cholinesterase inhibitors, corroborated by the
symptomology presented, which was similar to
that previously recorded after intoxications
with cholinesterase inhibitors, and the certainty
of contact with the carbamate methomyl.
The pharmacological changes in the
cholinergic system could be related to the cog-
nitive deﬁcits found. The mechanism of this
neurotoxic effect is uncertain. Bushnell et al.
(1995) demonstrated a phenomenon of toler-
ance to repeated doses of chlorpyrifos (OPs) in
rats due to the synaptic adaptation of mus-
carinic receptors (down-regulation). However,
this adaptation has a functional cost: The rats
showed cognitive deficits, even when the
cholinesterase level had returned to normal.
The inhibition of brain AChE by carba-
mates affects different subtypes of neuronal
nicotinic receptors, independently of AChE
inhibition. This implies that neuronal nicotinic
receptors are additional targets for some carba-
mate pesticides and that these receptors may
contribute to carbamate pesticide toxicology,
especially after long-term exposure (Smulders
et al. 2003).
Perhaps the underlying mechanism should
be sought in the role of the cholinesterase
enzyme. A current hypothesis proposes a com-
pensatory mechanism with functional conse-
quences, whereby cholinesterase activity
increases after the poisoning events, which is
explained by cholinesterase being quickly syn-
thesized in response to brain hyperexcitability
after cholinesterase inhibitor poisoning events
and after stress (Meshorer et al. 2002). AChE
inhibition causes an increase in ACh, activat-
ing pre- and postsynaptic cholinergic recep-
tors. There is an immediate transcriptional
regulation of genes coding for AChE, choline
acetyltransferase (ChAT), and vesicle ACh
transporter (VAChT), which reduces the
expression of ChAT and VAChT mRNA,
increasing the AChE mRNA (Grisaru et al.
1999).
This may be the case for PVM, who after
six poisoning events had very high levels of
plasma cholinesterase. Indeed, a year later,
both AMF and PVM showed above-normal
BuChE (Figure 1). BuChE, also called pseudo-
cholinesterase or plasma cholinesterase, is an
enzyme genetically different from AChE,
although they share some important functions,
such as ACh hydrolysis (Darvesh et al. 2003).
Individual susceptibility to cholinesterase
inhibitor compounds is due, in part, to indi-
vidual genetic variations of this enzyme
(Fontoura-da-Silva et al. 1996). Nevertheless,
it is widely used as a biomarker of both expo-
sure to cholinesterase inhibitors and recovery
from acute intoxications. A cholinergic crisis,
together with reduced levels of plasma BuChE
activity, leads to the diagnosis of over-
cholinergic syndrome (Martín-Rubí et al.
1995). Research in progress by our group
points to a strong correlation between the
number of poisoning events and plasmatic
cholinesterase level, which is higher in subjects
who have undergone several poisoning events
(Roldán-Tapia et al. 2000).
The underlying mechanism might be
found in the noncatalytic functions of
cholinesterases. Current studies support the
idea of a trophic function of the G1 form,
and possibly the G4 form, of this enzyme in
the central nervous system and neuro-
muscular junction during development
(Andres et al. 1997, 1998; Darvesh et al.
2003). The toxic effect of the synthesis of dif-
ferent forms of the enzyme is unknown but
might explain functional damage in the cen-
tral nervous system. In this regard, it has been
shown that an overexpression of AChE in
transgenic mice produces progressive neuro-
chemical, neuromorphological, and neuro-
cognitive alteration, at least in spatial memory
in adult mice (Andres et al. 1997, 1998; Beeri
et al. 1997, 1998). These studies lead us to
believe that changes in enzymatic level may
produce a pathological dysfunction that
explains the neuropsychological deﬁcits found
after poisoning by cholinesterase inhibitors
such as OP compounds and carbamates
(Kaufer et al. 1998).
Conclusions
Pesticide poisoning is a serious health problem
that affects the general population, speciﬁcally
people working with these compounds.
Pesticides are designed to kill, reduce, or repel
insects, fungi, and other organisms that can
threaten public health. However, when
improperly used or stored, these chemical
agents can also harm humans. Key risks are
cancer, birth defects, and damage to the ner-
vous system and to the functioning of the
endocrine system. Pesticides are known to
cause millions of acute poisoning cases per
year, of which at least 1 million require hospi-
talization. Between one and three agricultural
workers per every 100 worldwide suffer from
acute pesticide poisoning [United Nations
Environment Programme (UNEP) 2004]. The
contribution of pesticides to chronic diseases,
on the other hand, is unknown. Tackling the
risks of pesticide exposure and poisoning
requires comprehensive strategies. These strate-
gies should be designed at the local level and
supported regionally, nationally, and inter-
nationally. They should include research activi-
ties on how to develop effective economic and
legal instruments. In addition, they should
ensure that the public is informed, that health
conditions are monitored and, where neces-
sary, that treatment programs are established.
At the clinical level, our ﬁndings, together
with previous research, provide evidence that
cholinesterase inhibitor poisoning has both
short- and long-term neuropsychological
sequelae, through cholinesterase inhibition
and/or other unknown mechanisms, demon-
strating the utility of neuropsychological
examinations in detecting secondary central
nervous system dysfunction after pesticide
intoxication. Follow-up studies, controlling
for the type and amount of pesticides, AChE
level, different forms of the enzyme, and more
speciﬁc neurobehavioral tasks, will be needed
to demonstrate a possible effect of these sub-
stances on the central nervous system.
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